Page 12 - Breakthrough Devices Program News Today

Technologies including artificial intelligence-based diagnostic software may be changing how the disease is detected and treated in the future.

IQX Limited (NSX:IQX) has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Device Designation.

NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

On December 1, 2021, RefleXion Medical, Inc. (“RefleXion”), announced that the U.S. Food and Drug Administration (“FDA”) has granted the company breakthrough device designation for its...

Lungs among most common site for metastatic tumors 

The news comes just as Pear is finalizing its SPAC merger.

- It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years LONDON, Nov. 20, 2021 /PRNewswire/ -- Datar Cancer Genetics, a leading cancer research company focussed on early detection of cancers today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation'...

/PRNewswire/ -- Renovia Inc. ("Renovia"), a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that the...

/PRNewswire/ - The Breakthrough Device Designation is an FDA designation granted to devices that provide more effective treatment or diagnosis of...

/PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostic, and biologics advisory firm and clinical research organization (CRO) integrating U.S....